GENX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
GENX has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company